Mayne Pharma Group Limited declared a fully franked special dividend of approximately $47.3 million (2.72 cents per share) The Special Dividend and Capital Return are expected to be paid to shareholders on 27 January 2023, subject to the timing of feedback from the ATO and shareholder approval at Mayne Pharma's Annual General Meeting (AGM) to be held on the 30 November 2022.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
7.12 AUD | +4.25% | +2.30% | +15.77% |
Feb. 26 | Mayne Pharma Group Swings to Loss in Fiscal H1 Despite Revenue Growth; Shares Jump 15% | MT |
Feb. 25 | Transcript : Mayne Pharma Group Limited, H1 2024 Earnings Call, Feb 26, 2024 |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+15.77% | 357M | |
+17.88% | 44.31B | |
+19.87% | 22.17B | |
+13.05% | 14.62B | |
+8.06% | 13.12B | |
+39.21% | 11.58B | |
-8.96% | 6.96B | |
-0.05% | 6.79B | |
-8.87% | 5.73B | |
+6.50% | 5.03B |
- Stock Market
- Equities
- MYX Stock
- News Mayne Pharma Group Limited
- Mayne Pharma Group Limited Declares Fully Franked Special Dividend, Payable on 27 January 2023